Akademisyen
İLKNUR KESKİN
PROFESÖR
İSTANBUL MEDİPOL ÜNİVERSİTESİ TIP FAKÜLTESİ TEMEL TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Histoloji ve Embriyoloji
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 105
- Proje 0
- Kitap 0
- Bildiri 0
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
20
Q2
30
Q3
24
Q4
11
WoS (JCR)
Q1
19
Q2
12
Q3
26
Q4
23
TR Index
15
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
3
Ort. yüzdelik
60.7%
Üst %1 payı
0.0%
Üst %10 payı
3.3%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2025 Comparative Investigation of Cx3cr1-Expressing Cardiac Macrophages in Atrioventricular Nodes of Wild-Type and Catecholaminergic Polymorphic Ventricular Tachycardia Mouse Model. YÖKSİS SJR Q1 JCR Q3 OpenAlex 42.2%
- 2025 Evaluation of Perilipin Expression in Centrifuged Fat Grafts on Different Revolutions Per Minute and Duration Combinations YÖKSİS SJR Q1 JCR Q1 OpenAlex 71.7%
- 2025 Testicular Microbiome: May Influence Testicular Architecture and Spermatogenesis, and Predict Results of Microsurgical Testicular Sperm Extraction YÖKSİS SJR Q2 JCR Q4 OpenAlex 35.4%
- 2025 Investigating Neotenic and Metamorphic Axolotl Brain Complexity: A Stereological and Immunohistochemical Perspective YÖKSİS SJR Q2 JCR Q1 OpenAlex 84.1%
- 2025 Inhibition of pyroptosis by belnacasan: A potential strategy for mitigating acute lung injury and multiple organ dysfunction YÖKSİS SJR Q2 JCR Q1 OpenAlex 77.1%
- 2025 Anticancer Properties of Phenylboronic Acid in Androgen-Dependent (LNCaP) and Androgen-Independent (PC3) Prostate Cancer Cells via MAP Kinases by 2D and 3D Culture Methods YÖKSİS SJR Q3 JCR Q3 OpenAlex 1.6%
- 2025 A synergistic microemulsion approach with cetyl myristoleate and hyaluronic acid for enhanced osteoarthritis therapy: In vitro and in vivo evaluation YÖKSİS SJR Q2 JCR Q1 OpenAlex üst %10 OpenAlex 92.7%
- 2025 HMG-CoA reductase inhibition preserves testicular function after torsion/detorsion by modulating oxidative stress and AKT signaling YÖKSİS SJR Q1 JCR Q1 OpenAlex 81.3%
- 2024 Efficacy of one-hour negative pressure wound therapy and magnetic field energy in wound healing YÖKSİS SJR Q2 JCR Q3 OpenAlex 0.4%
- 2024 Therapeutic Effects of Mesenchymal Stem Cell Conditioned Medium in Rat Varicocele Model YÖKSİS SJR Q1 JCR Q1 OpenAlex 86.2%
- 2024 Unravelling the impact of COVID-19 on pregnancy: In aspect of placental histopathology and umbilical cord macrophage immunoactivity with neonatal outcomes YÖKSİS SJR Q2 JCR Q2 OpenAlex 81.8%
- 2024 Preliminary study on the impact of 900 MHz radiation on human sperm: An in vitro molecular approach YÖKSİS SJR Q2 JCR Q2 OpenAlex 80.7%
- 2024 mTOR Pathway Inhibition, Anticancer Activity and In Silico Calculations of Novel Hydrazone Derivatives in Two- and Three-Dimensional Cultured Type 1 Endometrial Cancer Cells. YÖKSİS SJR Q1 JCR Q1 OpenAlex 57.1%
- 2024 Investigation of the anticancer, antimigration and antiangiogenesis effects of an oxadiazole derivative in two- and three-dimensional cultured Ishikawa and Huvec cells; in vitro and in silico studies YÖKSİS TR Index OpenAlex 63.8%
- 2023 Effects of Vincamine on Testicular Dysfunction in Alloxan-induced Diabetic Male Rats YÖKSİS SJR Q2 JCR Q3 OpenAlex 72.4%
- 2023 Are ICSI results affected by months and seasons? A retrospective cohort study of fresh and frozen cycles YÖKSİS SJR Q2 JCR Q2 OpenAlex 21.3%
- 2023 Tissue Factor and Vascular Endothelial Growth Factor in Detecting Thromboembolic Complications in Diabetic Atherosclerotic Patients. YÖKSİS SJR Q3 JCR Q4 OpenAlex 39.5%
- 2022 Seminal trace elements and their relationship with sperm parameters YÖKSİS SJR Q2 JCR Q2 OpenAlex 76.2%
- 2022 Benzotriazole-oxadiazole hybrid compounds: Synthesis, Anticancer Activity, Molecular Docking and ADME Profiling Studies YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 95.4%
- 2022 Effect of oral use of various edible oils on wound healing in rats: randomized controlled experimental study YÖKSİS SJR Q3 OpenAlex 42.1%